{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:24:23Z","timestamp":1787671463059,"version":"build-2736575974"},"reference-count":8,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"DOI":"10.1182\/bloodadvances.2024012705","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:09:13Z","timestamp":1716919753000},"page":"2573-2574","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal stem cells: paving the way for myeloma onset?"],"prefix":"10.1182","volume":"8","author":[{"given":"Annamaria","family":"Gulla","sequence":"first","affiliation":[{"name":"1Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Fulciniti","sequence":"additional","affiliation":[{"name":"2Department of Medical Oncology, Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2024052815310336400_bib1","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/bloodadvances.2023011632","article-title":"Stromal alterations in patients with MGUS, smoldering myeloma and multiple myeloma","volume":"8","author":"Bogun","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"2024052815310336400_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41556-019-0444-9","article-title":"Dynamic responses of the haematopoietic stem cell niche to diverse stresses [published correction appears in Nat Cell Biol","volume":"22","author":"Batsivari","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2024052815310336400_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"2024052815310336400_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","article-title":"The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape","volume":"22","author":"de Jong","year":"2021","journal-title":"Nat Immunol"},{"issue":"13","key":"2024052815310336400_bib5","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2011-04-347484","article-title":"Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells","volume":"120","author":"Bruns","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2024052815310336400_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","article-title":"Myelodysplastic cells in patients\u00a0reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit","volume":"14","author":"Medyouf","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"19","key":"2024052815310336400_bib7","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"15","key":"2024052815310336400_bib8","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cells11152308","article-title":"Bone disease in multiple myeloma: biologic and clinical implications","volume":"11","author":"Bernstein","year":"2022","journal-title":"Cells"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2573\/2226533\/blooda_adv-2024-012705-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/10\/2573\/2226533\/blooda_adv-2024-012705-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T14:30:02Z","timestamp":1732113002000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/10\/2573\/516217\/Mesenchymal-stem-cells-paving-the-way-for-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012705","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}